Legal Representation
Attorney
Megan E. Spitz
USPTO Deadlines
Application History
37 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Apr 8, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Apr 8, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
Jul 27, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Jul 26, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
Jul 26, 2023 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
Jul 19, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Jul 19, 2023 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
Mar 2, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Feb 28, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Feb 28, 2023 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Feb 28, 2023 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Aug 10, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Aug 8, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Aug 8, 2022 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Aug 8, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Feb 18, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Feb 16, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Feb 16, 2022 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Feb 16, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Aug 31, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Aug 27, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Aug 27, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Aug 27, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Mar 2, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Jan 5, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Jan 5, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Dec 16, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Dec 3, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Nov 12, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Nov 12, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Nov 12, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
May 14, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
May 14, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
May 14, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
May 6, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Feb 20, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Feb 18, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Scientific laboratory services; calibration services for test medium supervision; calibration of pipettes; calibration of measuring apparatus in the context of legal metrology; testing services, namely, conducting tests for the validation of filter systems, bioreactors and fermenters and biosensors in the context of quality control for manufacturers of pharmaceutical products; conducting integrity tests for filter installation in the nature of quality control for others; quality control testing of cell banks, virus banks, raw materials of animal origin, bulk harvest and clinical batches regarding contamination with bacteria, fungi, yeasts, mycoplasma, adventitious viruses and any other potential contaminants; advisory and consultancy services relating to the aforementioned scientific laboratory, testing, calibration and quality control services; development of scientific and technical processes for the production of proteins; performing biological and chemical analysis of amino acids in protein samples; biological and chemical laboratory services, namely, scientific support of production processes relating to biological preparations and pharmaceuticals; scientific and technological services and research and design in the fields of chemistry, biochemistry, biology, bacteriology, pharmaceuticals, biotechnology and vaccines, namely, product characterization and release testing, cell based potency assays, virus screening assays, molecular biology and protein characterization, batch release testing, batch release testing with recombinant proteins, monoclonal antibodies, fusion proteins, gene therapy vectors, virus vaccines and cell based therapies, supporting assays for clinical trial analysis, antidrug antibody determination and residual DNA, development and release of vaccine and biologic products, and clinical research services, namely, collection, calibration and reporting of data in connection with clinical trials of pharmaceuticals; biosafety testing services for testing and product development of biologic products, vaccines, medicinal herbal products and complementary and alternative medicines; biosafety product, laboratory and manufacturing process testing services for the pharmaceutical, biotech and vaccine sectors; chemical, biochemical, biological and bacteriological analysis and research services; computer programming; consultancy relating to computer network design; system consultancy, namely, computer system analysis, filter system analysis and bioreactor analysis and consultancy relating to creating and changing the scale of systems consisting of computer, filter and bioreactor installations taking into consideration the mutual compatibility of these installations; technical verification and validation concepts, namely, testing, analysis and evaluation of the goods, manufacturing facilities and manufacturing processes of others to determine conformity with certification standards in particular for the pharmaceutical industry and for the food and drink industry; audits not for business purposes, namely, technical monitoring of the conformity of products, installations and methods using regulatory and legal specifications and guidelines for technical evaluation purposes; technical consultancy related to providing technical support for manufacturers of pharmaceutical products and for food and drink producers during audits, namely, during monitoring of the technological conformity of products, installations and methods using regulatory and legal specifications and guidelines related only to the technological aspects in the aforementioned fields; software development; software installation; software consultancy services, namely, consulting services in the field of selection, implementation, and use of computer software systems of others, business technology software consultation services, consulting services in the field of software as a services; computer software maintenance; computer software technical support services, namely installation of industrial process and laboratory equipment control computer software, troubleshooting of industrial process and laboratory equipment control computer software problems, troubleshooting in the nature of diagnosing computer software problems; biological research and analysis; chemical research and analysis, medical research; development of processes for the production of proteins, namely, process design, engineering, research in the field of protein production; product research and development cell line development; consultancy with regard to the technical development of scientific processes for the production of proteins and the development of cell lines; cell line and cell bank manufacturing; biological analysis being biosimilar analysis and testing services to determine product quality, product safety, conformity with certification standards; cell bank characterization in the nature of testing and analyzing cell banks for their compliance with safety and quality standards; providing information, advisory and consultancy services relating to the aforementioned services
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
042